These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19805354)

  • 21. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.
    Nian H; Delage B; Ho E; Dashwood RH
    Environ Mol Mutagen; 2009 Apr; 50(3):213-21. PubMed ID: 19197985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells.
    Yao H; Wang H; Zhang Z; Jiang BH; Luo J; Shi X
    Int J Cancer; 2008 Sep; 123(6):1255-61. PubMed ID: 18561315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.
    Chen L; Meng S; Wang H; Bali P; Bai W; Li B; Atadja P; Bhalla KN; Wu J
    Mol Cancer Ther; 2005 Sep; 4(9):1311-9. PubMed ID: 16170022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
    Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
    Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer.
    Seidel C; Schnekenburger M; Mazumder A; Teiten MH; Kirsch G; Dicato M; Diederich M
    Biochem Pharmacol; 2016 Jan; 99():31-52. PubMed ID: 26549368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor signalling in prostate cancer: the functional consequences of acetylation.
    Lavery DN; Bevan CL
    J Biomed Biotechnol; 2011; 2011():862125. PubMed ID: 21274273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors.
    Jadhavar PS; Ramachandran SA; Riquelme E; Gupta A; Quinn KP; Shivakumar D; Ray S; Zende D; Nayak AK; Miglani SK; Sathe BD; Raja M; Farias O; Alfaro I; Belmar S; Guerrero J; Bernales S; Chakravarty S; Hung DT; Lindquist JN; Rai R
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5222-5228. PubMed ID: 27717544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of deacetylation activity of Hdac6 affects emotional behavior in mice.
    Fukada M; Hanai A; Nakayama A; Suzuki T; Miyata N; Rodriguiz RM; Wetsel WC; Yao TP; Kawaguchi Y
    PLoS One; 2012; 7(2):e30924. PubMed ID: 22328923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells.
    Khurana N; Talwar S; Chandra PK; Sharma P; Abdel-Mageed AB; Mondal D; Sikka SC
    Int J Oncol; 2016 Oct; 49(4):1609-19. PubMed ID: 27499349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone.
    Murphy PJ; Morishima Y; Kovacs JJ; Yao TP; Pratt WB
    J Biol Chem; 2005 Oct; 280(40):33792-9. PubMed ID: 16087666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
    Myzak MC; Karplus PA; Chung FL; Dashwood RH
    Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
    DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
    Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
    Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
    Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.
    Reebye V; Querol Cano L; Lavery DN; Brooke GN; Powell SM; Chotai D; Walker MM; Whitaker HC; Wait R; Hurst HC; Bevan CL
    Mol Endocrinol; 2012 Oct; 26(10):1694-706. PubMed ID: 22899854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugging the HDAC6-HSP90 interplay in malignant cells.
    Krämer OH; Mahboobi S; Sellmer A
    Trends Pharmacol Sci; 2014 Oct; 35(10):501-9. PubMed ID: 25234862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
    Wang LG; Liu XM; Chiao JW
    Carcinogenesis; 2006 Oct; 27(10):2124-32. PubMed ID: 16704988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
    Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
    Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.
    Pledgie-Tracy A; Sobolewski MD; Davidson NE
    Mol Cancer Ther; 2007 Mar; 6(3):1013-21. PubMed ID: 17339367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.